MedPath

Knowledge and acceptance about postpartum insertion of intrauterine device among antenatal cases

Recruiting
Conditions
Antenatal mothers who have completed 37 weeks of POG
Registration Number
CTRI/2018/01/011455
Lead Sponsor
Rejani R
Brief Summary

The study is an experimental study to assess the efficacy of structured teaching programme on knowledge and acceptance of postpartum intra uterine device (PPIUCD) as method of contraception as compared to the routine antenatal counselling among mothers attending  antenatal OPD in a selected tertiary care hospital .100 Antenatal mothers who have completed 37 wks POG will be recruited and randomised into two groups.The experimental group will get structured teaching about PPIUCD and control group will get counselling on all contraceptive methods.Pre and post knowledge and acceptance will be assessed using a structured tool consisting of three parts.Post delivery acceptance of PPIUCD will be monitored and thus efficacy of structured teaching will be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
100
Inclusion Criteria

1.Registered term antenatal mothers who completed 37 weeks of gestation 2.Antenatal mothers fit as per WHO Medical Eligibility Criteria (MEC) 3.Willing to participate in the study 4.Who will deliver in the maternity setting of the study centre.

Exclusion Criteria

1.Antenatal mothers with bad obstetrical history.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acceptance of PPIUCD as method of contraceptionSoon after delivery
Secondary Outcome Measures
NameTimeMethod
Acceptance of Small family normAcceptance of Small family norm

Trial Locations

Locations (1)

Armed Forces Medical College

🇮🇳

Pune, MAHARASHTRA, India

Armed Forces Medical College
🇮🇳Pune, MAHARASHTRA, India
Rejani R
Principal investigator
9769885329
rrajani.pillai@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.